[go: up one dir, main page]

BRPI0603911A - composição anidra contendo um sistema de tampão ácido-ácido - Google Patents

composição anidra contendo um sistema de tampão ácido-ácido

Info

Publication number
BRPI0603911A
BRPI0603911A BRPI0603911-1A BRPI0603911A BRPI0603911A BR PI0603911 A BRPI0603911 A BR PI0603911A BR PI0603911 A BRPI0603911 A BR PI0603911A BR PI0603911 A BRPI0603911 A BR PI0603911A
Authority
BR
Brazil
Prior art keywords
acid
composition containing
buffer system
vaginal
anhydrous composition
Prior art date
Application number
BRPI0603911-1A
Other languages
English (en)
Inventor
Nawaz Ahmad
Cheng-Ji Cui
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0603911A publication Critical patent/BRPI0603911A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

"COMPOSIçãO ANIDRA CONTENDO UM SISTEMA DE TAMPãO áCIDO-áCIDO". A presente invenção refere-se a composições anidras e métodos de manutenção do pH vaginal saudável para controlar o odor vaginal. Tais composições podem ser aplicadas à área vaginal para diminuir o pH vaginal e auxiliar na manutenção de tal pH durante um período de tempo.
BRPI0603911-1A 2005-09-12 2006-09-12 composição anidra contendo um sistema de tampão ácido-ácido BRPI0603911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71623205P 2005-09-12 2005-09-12
US71644105P 2005-09-13 2005-09-13

Publications (1)

Publication Number Publication Date
BRPI0603911A true BRPI0603911A (pt) 2007-04-27

Family

ID=37606938

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603911-1A BRPI0603911A (pt) 2005-09-12 2006-09-12 composição anidra contendo um sistema de tampão ácido-ácido

Country Status (5)

Country Link
EP (1) EP1782794A3 (pt)
JP (1) JP2007077150A (pt)
AU (1) AU2006209263A1 (pt)
BR (1) BRPI0603911A (pt)
CA (1) CA2559407A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
JP7424636B2 (ja) 2017-10-06 2024-01-30 ジェディア バイオテック エービー 微生物感染症の治療および／または予防用グルコン酸誘導体
KR102061302B1 (ko) * 2018-04-05 2019-12-31 주식회사 벤스랩 항균 및 소취 기능성 여성세정제 조성물
GB201808567D0 (en) * 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Pharmaceutical compositions
JP2023532089A (ja) * 2020-06-30 2023-07-26 ビレオ システムズ インコーポレイテッド 臭気及びかゆみを制御するための組成物並びにその投与方法及び投与装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
GR940100370A (el) * 1993-07-28 1994-07-26 Johnson & Johnson Consumer Products Inc. Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition

Also Published As

Publication number Publication date
CA2559407A1 (en) 2007-03-12
EP1782794A2 (en) 2007-05-09
AU2006209263A1 (en) 2007-03-29
JP2007077150A (ja) 2007-03-29
EP1782794A3 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
ATE329587T1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
DE69939661D1 (de) Hautdesodorierende und desinfizierende zubereitung
ATE421248T1 (de) Antiseptische zusammensetzungen und verfahren
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
DE60312017D1 (de) Sulfonderivate zur hemmung von gamma-secretase
ATE540684T1 (de) Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
PA8599601A1 (es) Compuestos de benzopirano utiles para tratar estados inflamatorios
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
EP2046361A4 (en) OSTEOUS AMPLIFIER COMPOSITION
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BRPI0517435A (pt) triazóis úteis como inibidores de proteìna cinase
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
NI200300045A (es) Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
ATE336226T1 (de) Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure
BRPI0603911A (pt) composição anidra contendo um sistema de tampão ácido-ácido
UA97346C2 (ru) Стабильная эмульсионная композиция
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
BRPI0603783A (pt) composições e métodos para redução do ph vaginal
ATE556053T1 (de) Piperidinderivate zur behandlung von alzheimer- krankheit
AR028698A1 (es) Heterociclos hetaril-substituidos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired